Company expands team, university partnerships, and internship programs to build long-term biologics talent pipeline TUSTIN, CA, May 18, 2026 — Avid Bioservices, a leading biologics CDMO, today announced the […]
Read moreExperienced life sciences leader to drive global commercial strategy and accelerate growth across early- and late-phase biologics programs TUSTIN, Calif., May 11, 2026 — Avid Bioservices, Inc., a dedicated biologics contract development and […]
Read morePress Release: Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California Costa Mesa, Calif. – [February 24, 2026] – Avid Bioservices, Inc., a dedicated biologics CDMO, today announced the grand […]
Read moreSeasoned business and finance leader brings growth mindset to support Avid’s next phase expansion and client execution TUSTIN, Calif. — [January 15, 2026] — Avid Bioservices, a leading contract development […]
Read moreThe newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth. TUSTIN, Calif., November 10, 2025 – Avid […]
Read moreTustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]
Read moreSOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]
Read more